Keros Therapeutics, Inc.
KROS
$10.10
-$0.56-5.25%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 257.61M | 281.50M | 287.42M | 693.47M | 690.22M |
| Total Receivables | 3.30M | 3.51M | 20.85M | 5.57M | 17.74M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.31M | 1.74M | 2.76M | 4.16M | 5.56M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 3.66M | 3.93M | 4.40M | 16.12M | 19.30M |
| Total Current Assets | 266.88M | 290.68M | 315.43M | 719.31M | 732.81M |
|
|
|||||
| Total Current Assets | 266.88M | 290.68M | 315.43M | 719.31M | 732.81M |
| Net Property, Plant & Equipment | 19.27M | 20.17M | 21.14M | 22.03M | 22.91M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.45M | 1.45M | 1.45M | 1.45M | 1.45M |
| Total Assets | 287.60M | 312.29M | 338.02M | 742.78M | 757.17M |
|
|
|||||
| Total Accounts Payable | 1.82M | 1.49M | 1.97M | 2.30M | 5.27M |
| Total Accrued Expenses | 7.20M | 5.37M | 12.45M | 14.96M | 19.62M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.60M | 2.50M | 2.41M | 2.32M | 2.23M |
| Total Finance Division Other Current Liabilities | 537.00K | 3.49M | 3.59M | 4.51M | 7.60M |
| Total Other Current Liabilities | 537.00K | 3.49M | 3.59M | 4.51M | 7.60M |
| Total Current Liabilities | 12.15M | 12.85M | 20.41M | 24.09M | 34.71M |
|
|
|||||
| Total Current Liabilities | 12.15M | 12.85M | 20.41M | 24.09M | 34.71M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 13.13M | 13.81M | 14.48M | 15.11M | 15.72M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 25.28M | 26.66M | 34.89M | 39.20M | 50.43M |
|
|
|||||
| Common Stock & APIC | 1.18B | 1.18B | 1.17B | 1.16B | 1.16B |
| Retained Earnings | -534.18M | -505.47M | -481.77M | -458.30M | -451.02M |
| Treasury Stock & Other | -384.56M | -384.56M | -384.56M | -- | -- |
| Total Common Equity | 262.32M | 285.63M | 303.13M | 703.58M | 706.73M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 262.32M | 285.63M | 303.13M | 703.58M | 706.73M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 262.32M | 285.63M | 303.13M | 703.58M | 706.73M |
|
|
|||||